Skip to main content

Advertisement

SpringerLink
Log in

Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population

  • Research Article
  • Published:
Tumor Biology

Abstract

Osteosarcoma (OS) is the most common bone malignancy worldwide. The vascular endothelial growth factor (VEGF) gene plays an important role in the pathogenesis of OS. The objective of this study aimed to detect the potential association between VEGF genetic polymorphisms and OS susceptibility in Chinese Han population. We recruited 330 OS patients and 342 cancer-free controls in this case–control study. Three single-nucleotide polymorphisms (SNPs) (−634 G > C, +936 C > T, and +1612 G > A) of the VEGF gene were investigated by using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) method and confirmed by direct DNA sequencing. Among these SNPs, we found that the genotypes/alleles of +936 C > T were statistically associated with the increased risk of OS (TT versus (vs.) CC: OR = 2.70, 95 % CI 1.34–5.45, χ2 = 8.2271, p = 0.0041; T vs. C: OR = 1.31, 95 % CI 1.02–1.68, χ2 = 4.3861, p = 0.0362). The T allele and TT genotype of +936 C > T could be factors that increase the risk for susceptibility to OS. The results from this study suggest that VEGF genetic variants are potentially related to OS susceptibility in Chinese Han population and might be used as molecular markers for assessing OS susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115(7):1531–43. doi:10.1002/cncr.24121.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Hameed M, Dorfman H. Primary malignant bone tumors—recent developments. Semin Diagn Pathol. 2011;28(1):86–101.

    Article  PubMed  Google Scholar 

  3. Zhu L, McManus MM, Hughes DP. Understanding the biology of bone sarcoma from early initiating events through late events in metastasis and disease progression. Frontiers Oncology. 2013;3:230. doi:10.3389/fonc.2013.00230.

    Article  CAS  Google Scholar 

  4. Patio-Garcia A, Sotillo-Pieiro E, Modesto C, Sierrases-Maga L. Analysis of the human tumour necrosis factor-alpha (TNFalpha) gene promoter polymorphisms in children with bone cancer. J Med Genet. 2000;37(10):789–92.

    Article  CAS  PubMed  Google Scholar 

  5. Savage SA, Burdett L, Troisi R, Douglass C, Hoover RN, Chanock SJ. Germ-line genetic variation of TP53 in osteosarcoma. Pediatr Blood Cancer. 2007;49(1):28–33. doi:10.1002/pbc.21077.

    Article  PubMed  Google Scholar 

  6. Savage SA, Woodson K, Walk E, Modi W, Liao J, Douglass C, et al. Analysis of genes critical for growth regulation identifies insulin-like growth factor 2 receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol, Biomarkers Prev. 2007;16(8):1667–74. doi:10.1158/1055-9965.EPI-07-0214.

    Article  CAS  Google Scholar 

  7. Koshkina NV, Kleinerman ES, Li G, Zhao CC, Wei Q, Sturgis EM. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. J Pediatr Hematol/Oncol. 2007;29(12):815–21. doi:10.1097/MPH.0b013e3181581506.

    Article  CAS  Google Scholar 

  8. Toffoli G, Biason P, Russo A, De Mattia E, Cecchin E, Hattinger CM, et al. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clin Cancer Res. 2009;15(10):3550–6. doi:10.1158/1078-0432.CCR-08-2249.

    Article  CAS  PubMed  Google Scholar 

  9. Hu YS, Pan Y, Li WH, Zhang Y, Li J, Ma BA. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study. BMC Cancer. 2010;10:169. doi:10.1186/1471-2407-10-169.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Mirabello L, Berndt SI, Seratti GF, Burdett L, Yeager M, Chowdhury S, et al. Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis. 2010;31(8):1400–4. doi:10.1093/carcin/bgq117.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Mirabello L, Yu K, Berndt SI, Burdett L, Wang Z, Chowdhury S, et al. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer. 2011;11:209. doi:10.1186/1471-2407-11-209.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. He J, Wang J, Wang D, Dai S, Yv T, Chen P, et al. Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese. Endocrine Journal. 2013;60(11):1215–20.

    Google Scholar 

  13. Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, et al. Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet. 2013;45(7):799–803. doi:10.1038/ng.2645.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Kushner EJ, Bautch VL. Building blood vessels in development and disease. Curr Opin Hematol. 2013;20(3):231–6. doi:10.1097/MOH.0b013e328360614b.

    PubMed  Google Scholar 

  15. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett. 2006;580(12):2879–87. doi:10.1016/j.febslet.2006.03.087.

    Article  CAS  PubMed  Google Scholar 

  16. Yang J, Yang D, Sun Y, Sun B, Wang G, Trent JC, et al. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer. 2011;117(21):4925–38. doi:10.1002/cncr.26116.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res. 2000;6(2):572–7.

    CAS  PubMed  Google Scholar 

  18. DuBois S, Demetri G. Markers of angiogenesis and clinical features in patients with sarcoma. Cancer. 2007;109(5):813–9. doi:10.1002/cncr.22455.

    Article  CAS  PubMed  Google Scholar 

  19. Lammli J, Fan M, Rosenthal HG, Patni M, Rinehart E, Vergara G, et al. Expression of vascular endothelial growth factor correlates with the advance of clinical osteosarcoma. Int Orthop. 2012;36(11):2307–13. doi:10.1007/s00264-012-1629-z.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Vincenti V, Cassano C, Rocchi M, Persico G. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation. 1996;93(8):1493–5.

    Article  CAS  PubMed  Google Scholar 

  21. Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine+. 2000;12(8):1232–5. doi:10.1006/cyto.2000.0692.

    CAS  PubMed  Google Scholar 

  22. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 2000;37(6):443–8. doi:10.1159/000054076.

    Article  CAS  PubMed  Google Scholar 

  23. Lee SJ, Lee SY, Jeon HS, Park SH, Jang JS, Lee GY, et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol, Biomarkers Prev. 2005;14(3):571–5. doi:10.1158/1055-9965.EPI-04-0472.

    Article  CAS  Google Scholar 

  24. Hofmann G, Langsenlehner U, Renner W, Langsenlehner T, Yazdani-Biuki B, Clar H, et al. Common single-nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol. 2008;134(5):591–5. doi:10.1007/s00432-007-0322-x.

    Article  CAS  PubMed  Google Scholar 

  25. Yapijakis C, Vairaktaris E, Vassiliou S, Vylliotis A, Nkenke E, Nixon AM, et al. The low VEGF production allele of the +936C/T polymorphism is strongly associated with increased risk for oral cancer. J Cancer Res Clin Oncol. 2007;133(10):787–91. doi:10.1007/s00432-007-0240-y.

    Article  CAS  PubMed  Google Scholar 

  26. Li YZ, Wang LJ, Li X, Li SL, Wang JL, Wu ZH, et al. Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies. Genet Mol Res. 2013;12(2):1035–44. doi:10.4238/2013.April.2.20.

    Article  CAS  PubMed  Google Scholar 

  27. Jiang Y, Tang JY, Wu Y, Zhao TF. Vascular endothelial growth factor gene polymorphisms and the risk of endometriosis: a systematic review. Zhonghua Fu Chan Ke Za Zhi. 2012;47(3):179–84.

    CAS  PubMed  Google Scholar 

  28. Zhou Y, Hu W, Zhuang W, Liu GJ, Wu TX, Yao X, et al. Vascular endothelial growth factor (VEGF) +936 C/T gene polymorphisms and gastric cancer risk: a meta-analysis involving 4,138 subjects. Int J Biol Markers. 2010;25(4):213–8.

    CAS  PubMed  Google Scholar 

  29. Jiang H, Lian M, Xie J, Li J, Wang M. Three single-nucleotide polymorphisms of the vascular endothelial growth factor (VEGF) gene and glioma risk in a Chinese population. The Journal of International Medical Research. 2013. doi:10.1177/0300060513498667.

  30. Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D, et al. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther. 2009;8(9):2496–508. doi:10.1158/1535-7163.MCT-09-0302.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer. 2002;2(10):795–803. doi:10.1038/nrc909.

    Article  CAS  PubMed  Google Scholar 

  32. Simonetti O, Lucarini G, Rubini C, Goteri G, Zizzi A, Staibano S, et al. Microvessel density and VEGF, HIF-1alpha expression in primary oral melanoma: correlation with prognosis. Oral Dis. 2013;19(6):620–7. doi:10.1111/odi.12048.

    Article  CAS  PubMed  Google Scholar 

  33. Bandoh N, Hayashi T, Takahara M, Kishibe K, Ogino T, Katayama A, et al. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis. Cancer Lett. 2004;208(2):215–25. doi:10.1016/j.canlet.2003.11.031.

    Article  CAS  PubMed  Google Scholar 

  34. Iordache S, Saftoiu A, Georgescu CV, Ramboiu S, Gheonea DI, Filip M, et al. Vascular endothelial growth factor expression and microvessel density—two useful tools for the assessment of prognosis and survival in gastric cancer patients. J Gastrointest Liver Dis. 2010;19(2):135–9.

    Google Scholar 

  35. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E. VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer. 2004;46(3):293–8. doi:10.1016/j.lungcan.2004.04.037.

    Article  PubMed  Google Scholar 

  36. Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, et al. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer (Journal International du Cancer). 2003;106(4):468–71. doi:10.1002/ijc.11238.

    Article  CAS  PubMed  Google Scholar 

  37. Kataoka N, Cai Q, Wen W, Shu XO, Jin F, Gao YT, et al. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women. Cancer Epidemiol, Biomark Prev. 2006;15(6):1148–52. doi:10.1158/1055-9965.EPI-05-0871.

    Article  CAS  Google Scholar 

  38. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, et al. The VEGF_936_C > T 3'UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett. 2008;262(1):71–6. doi:10.1016/j.canlet.2007.11.029.

    Article  CAS  PubMed  Google Scholar 

  39. Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C > T) gene and colon cancer in Korea. Anticancer Res. 2008;28(2B):1271–6.

    CAS  PubMed  Google Scholar 

  40. Bae SJ, Ahn DH, Hong SP, Kang H, Hwang SG, Oh D, et al. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C > T) gene and patients with stomach cancer. Yonsei Med J. 2008;49(5):783–91. doi:10.3349/ymj.2008.49.5.783.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  41. Yu F, Miao J. Significant association between cytotoxic T lymphocyte antigen 4 +49G > A polymorphism and risk of malignant bone tumors. Tumour Biology. 2013. doi:10.1007/s13277-013-0908-7.

  42. Gu F, Pfeiffer RM, Bhattacharjee S, Han SS, Taylor PR, Berndt S, et al. Common genetic variants in the 9p21 region and their associations with multiple tumours. Br J Cancer. 2013;108(6):1378–86. doi:10.1038/bjc.2013.7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. He M, Wang Z, Zhao J, Chen Y, Wu Y. COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death. Tumour Biology. 2013. doi:10.1007/s13277-013-1172-6.

  44. Wang J, Nong L, Wei Y, Qin S, Zhou Y, Tang Y. Association of interleukin-12 polymorphisms and serum IL-12p40 levels with osteosarcoma risk. DNA Cell Biol. 2013;32(10):605–10. doi:10.1089/dna.2013.2098.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the grant from Ningxia Natural Science fund (no. NZ11154).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Orthopedics, Ningxia People’s Hospital, Yinchuan, Ningxia Province, 750021, People’s Republic of China

    Zhen Wang, Peng Wen, Xiaojun Luo, Xiaomin Fang, Qingfeng Wang, Feng Ma & Jinhan Lv

Authors
  1. Zhen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peng Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaojun Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaomin Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qingfeng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Feng Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jinhan Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jinhan Lv.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Z., Wen, P., Luo, X. et al. Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population. Tumor Biol. 35, 3605–3610 (2014). https://doi.org/10.1007/s13277-013-1475-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1475-7

Keywords

Search

Navigation